Neurocrine Bioscience buy Truist Financial Co.
Start price
08.01.26
/
50%
€116.75
Target price
08.01.27
€144.77
Performance (%)
-1.24%
Price
10:55
€115.30
Summary
This prediction is currently active. With a performance of -1.24%, the BUY prediction by Truist_Financial_Co_ is trending in the wrong direction. This prediction currently runs until 08.01.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | -1.24% |
| iShares Core DAX® | 2.659% |
| iShares Nasdaq 100 | 0.916% |
| iShares Nikkei 225® | 2.426% |
| iShares S&P 500 | 1.230% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target lowered by analysts at Truist Financial Corporation from $172.00 to $169.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€119.35
30.10.25
30.10.25
€148.09
30.10.26
30.10.26
-3.39%
10:55
10:55
